Replies to post #125543 on Biotech Values

[iwfal]

EXEL -

I just read through the slide deck presented at ASCO, and they did show the change in biomarkers for both bisphosphonate-naive and bisphosphonate-treated patients.

They also showed just as much change in CTx in the non-PC patients with no known bone mets as they did in the PC patients with known bone mets. Not saying this means the drug is not working - but the clarity is not particularly high IMO.